NDC | 68163-738-09 |
Set ID | 8a166067-b492-4742-b74c-28fac87c8d70 |
Category | HUMAN OTC DRUG LABEL |
Packager | Raritan Pharmaceuticals Inc |
Generic Name | |
Product Class | alpha-1 Adrenergic Agonist |
Product Number | |
Application Number | PART341 |
- Active ingredients (in each 20 mL)
- Purposes
-
Uses
- •
- helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
- •
- temporarily relieves:
- •
- cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants
- •
- the intensity of coughing
- •
- the impulse to cough to help you get to sleep
- •
- nasal congestion due to a cold
-
Warnings
Do not use
- ▪
- if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
- •
- heart disease
- •
- high blood pressure
- •
- thyroid disease
- •
- diabetes
- •
- trouble urinating due to an enlarged prostate gland
- •
- persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis or emphysema
- •
- cough that occurs with too much phlegm (mucus)
-
Directions
- •
- do not take more than 6 doses in a 24-hour period
- •
- measure only with dosing cup provided.
- •
- do not use dosing cup with other products
- •
- dose as follows or as directed by a doctor
- •
- mL=milliliter
- •
- adults and children 12 years of age and older: 20 mL in dosing cup provided every 4 hours
- •
- children under 12 years of age: Do not use
- Other information
- Inactive ingredients
- Questions or comments?
-
Principal Display Panel
DRx CHOICE®
*Compare to the active ingredients Maximum Strength Mucinex® Fast-Max™ Severe Congestion & Cough.
Maximum Strength
Mucus Relief
Severe Congestion and Cough
Dextromethorphan HBr 20 mg Cough Suppressant
Guaifenesin - EXPECTORANT
Phenylephrine HCI - Nasal Decongestant
- •
- Controls Cough
- •
- Relieves Nasal & Chest Congestion
- •
- Thins & Loosens Mucus
FOR AGES 12 +
9 FL OZ (266 mL)
TAMPER EVIDENT: DO NOT USE IF PRINTED SEAL UNDER CAP IS BROKEN OR MISSING.
PEEL CORNER TO READ COMPLETE DRUG FACTS AND INFORMATION
‡Maximum Strength per 4 hour dose.
Manufactured by:
Raritan Pharmaceuticals
8 Joanna Court,
East Brunswick, NJ 08816
*This product is not manufactured or distributed by Reckitt Benckiser, distributor of Maximum Strength Mucinex® Fast-Max® Severe Congestion & Cough.
-
INGREDIENTS AND APPEARANCE
MUCUS RELIEF SEVERE CONGESTION AND COUGH MAXIMUM STRENGTH
dextromethorphan hbr, guaifenesin, phenylephrine hcl liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:68163-738 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DEXTROMETHORPHAN HYDROBROMIDE (UNII: 9D2RTI9KYH) (DEXTROMETHORPHAN - UNII:7355X3ROTS) DEXTROMETHORPHAN HYDROBROMIDE 20 mg in 20 mL GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN 400 mg in 20 mL PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE 10 mg in 20 mL Inactive Ingredients Ingredient Name Strength ANHYDROUS CITRIC ACID (UNII: XF417D3PSL) EDETATE DISODIUM (UNII: 7FLD91C86K) FD&C BLUE NO. 1 (UNII: H3R47K3TBD) FD&C RED NO. 40 (UNII: WZB9127XOA) POTASSIUM CITRATE (UNII: EE90ONI6FF) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) PROPYL GALLATE (UNII: 8D4SNN7V92) WATER (UNII: 059QF0KO0R) SODIUM BENZOATE (UNII: OJ245FE5EU) SORBITOL (UNII: 506T60A25R) SUCRALOSE (UNII: 96K6UQ3ZD4) XANTHAN GUM (UNII: TTV12P4NEE) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:68163-738-09 266 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 02/05/2019 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part341 02/05/2019 Labeler - Raritan Pharmaceuticals Inc (127602287)